Listing 1 - 10 of 16 | << page >> |
Sort by
|
Choose an application
This book is intended to act as an up-to-date reference point and knowledge developer for all readers interested in the area of gastroenterology and in particular, Ulcerative Colitis. All authors of the chapters are experts in their fields of publication, and deserve individual credit and praise for their contributions to the world of Ulcerative Colitis. We hope that you will find this publication informative, stimulating, and a reference point for the area of Ulcerative colitis as we move forward in our understanding of the field of medicine.
Ulcerative colitis. --- Colitis --- Inflammatory bowel diseases --- Hepatology
Choose an application
Ulcerative Colitis (UC) is a rapidly evolving medical field, and will continue to be very exiting in the next few decades. Although the underlying cause of this disease is still unknown, results in research dealing with various issues related to this disease are published every day. Chapters included in this book review the most recent literature on related advancements in regard to this chronic disease, which is controllable but not curable. Aspects like epidemiology, pathophysiology, genetics, incriminated etiologies, clinical aspects, complications, and disease management, including advancements in the diagnostic and therapeutic options, were documented by well known clinicians, researchers, and world wide authorities in their fields. This book on UC will be a valuable addition to each doctor's library interested in this subject, or for physicians dealing with patients suffering from this disease. Authors have also included figures and diagrams to depict their point, and to easily reach the minds of the readers in the simplest way.
Ulcerative colitis. --- Colitis --- Inflammatory bowel diseases --- Hepatology
Choose an application
This book is intended to act as an up to date reference point and knowledge developer for all readers interested in the area of gastroenterology and in particular Ulcerative Colitis. All of the chapter authors are experts in their fields of publication and deserve individual credit and praise for their contributions to the world of Ulcerative Colitis. We hope that you will find this publication informative, stimulating and a reference point for the area of Ulcerative colitis as we move forward in our understanding of the field of medicine.
Ulcerative colitis --- Treatment. --- Colitis --- Inflammatory bowel diseases --- Hepatology
Choose an application
80% of the bodies’ immune cells are harbored within the intestine. They are only separated from 1014 microorganisms by a single layer of intestinal epithelial cells and a secreted superficial mucus layer. Therefore, the intestinal epithelial surface represents a main frontier in host defense. Providing an intact mucosal barrier is vital for the host to limit bacterial entry and spread to the circulation. This specialized localization requires dynamic responses of intestinal epithelial cells to both pathogen- and immune-derived signals. Moreover, emergency barriers are needed in the setting of epithelial damage, which allow provisional microbial control and a timely restitution of mucosal integrity. Epithelial cells constantly interact with subjacent immune cells and fibroblasts, actively directing the immune response and also shaping the luminal microbiota. Epithelial dysfunction has been appreciated in recent years as a driving element in the pathogenesis of Inflammatory Bowel Diseases (IBD). Additionally, primary immune deficiencies may manifest in the form of chronic intestinal inflammation mimicking features of IBD. Recent advances in the techniques of epithelial cell culture and the discovery of new immune cell types and cellular properties have tremendously advanced the understanding in this interesting field of research. In this research topic, we want to focus on the complex interaction of intestinal epithelial cells, luminal flora and adjacent immune cells and invite manuscripts which highlight the dynamic responses of both epithelium and immune cells under steady-state or inflammatory conditions, and envision how this may be translated to the benefit of patient-care.
lymphocytes --- inflammatory bowel diseases --- immune system --- intestinal epithelium --- mucosal immunity
Choose an application
Inflammatory bowel disease is a chronic immune-mediated inflammation of the gastrointestinal tract of unknown origin, which includes Crohn's disease, ulcerative colitis, and inflammatory bowel disease of unclassified type. It is associated with different intestinal and extraintestinal manifestations like different neurological and psychiatric disorders. Histology is an important tool in the diagnosis and prognosis of inflammatory bowel disease and has an increasing part in patients' management. The objective of treatment is to make and keep long-lasting remission by immunosuppressive treatment like corticosteroids, thiopurines, and monoclonal antibodies directed against tumor necrosis factor alpha. Therapeutic drug monitoring of thiopurines by measuring levels of their metabolites has been proposed as a potentially effective tool in optimizing therapy in inflammatory bowel disease. Diets and their components influence microbiota of the intestine, function of the epithelial barrier, immune response, and other factors that have an important role in development and treatment of inflammation in the gut mucosa.
Inflammatory bowel diseases. --- Inflammatory bowel diseases --- IBD (Disease) --- Inflammatory bowel disease --- Intestines --- Gastroenteritis --- Inflammation --- Medicine --- Gastroenterology --- Health Sciences
Choose an application
The incidence of chronic inflammatory and autoimmune diseases is steadily increasing. Inflammatory bowel disease (IBD) is one example of a chronic inflammatory disease, which primarily affects the intestine but may also affect extraintestinal organs. The exact pathogenesis of IBD is currently unknown. However, it is clear that the pathogenesis is complex, involving barrier defects, changes in the intestinal microbiome, and chronic immune activation. This book aims to summarize basic aspects of these complex interactions between barrier function, microbiome, and the immune system. Of note, there is currently no cure for IBD. However, several therapies have evolved in the last years, which are overall able to-at least temporarily-suppress IBD. These therapies and the underlying mechanism are discussed.
Inflammatory bowel diseases. --- IBD (Disease) --- Inflammatory bowel disease --- Intestines --- Gastroenteritis --- Inflammation --- Medicine --- Hepatology --- Gastroenterology --- Health Sciences
Choose an application
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
microbiome --- gut microbiota --- mucosal immunology --- intestinal immunity --- intestinal homeostasis --- inflammatory bowel diseases --- Crohn's diseases --- ulcerative colitis
Choose an application
In this book, several important points regarding Crohn's disease are discussed. In the first section, we focus on etiopathogeny of Crohn's disease and the recent advances in our overall understanding of the disease - specifically, the role of the gut epithelium, alterations of the epithelial crypts, and the roles of the different cytokines in the pathophysiology of Crohn's disease. In the second section, a diagnosis of Crohn's disease is discussed. Another particular area of focus is in the diagnosis of intestinal tuberculosis, and the role of mycobacterium avium in Crohn's disease. In the third and final section, the management of Crohn's disease is discussed, with a focus on recent evidence-based medicine recommendations.
Crohn's disease --- Diagnosis. --- Colitis, Granulomatous --- Crohn disease --- Enteritis, Regional --- Granulomatous colitis --- Granulomatous enteritis --- Ileitis, Regional --- Ileocolitis --- Regional enteritis --- Regional ileitis --- Terminal enteritis --- Inflammatory bowel diseases --- Hepatology
Choose an application
Chronic intestinal diseases are increasing around the world. With poor quality of life and expensive healthcare costs, the patients demand novel approaches and treatments for better clinical outcomes. This book illustrates the state of the art and the envisaged near future in the management of these pathologies.
chronic intestinal pseudo-obstruction --- parenteral nutrition --- pediatrics --- myopathy --- neuropathy --- IBS --- microbiota --- visceral hypersensitivity --- colorectal motility --- inflammatory bowel disease --- Crohn’s disease --- ulcerative colitis --- anti-TNF --- ustekinumab --- vedolizumab --- postoperative complications --- surgery --- preoperative therapy --- biologic therapy --- bio-naïve --- IBD --- pro-inflammatory cytokines --- lymphocyte migration --- treatment --- inflammatory bowel diseases --- biologic treatment --- combination --- n/a --- Crohn's disease --- bio-naïve
Choose an application
A peer-reviewed, online-only, open access journal. Publishes engaging and informative content that catalyzes dialogue on state-of-the-art comprehensive care for patients with inflammatory bowel disease (IBD) alongside the latest research to advance prevention, treatment and cures. The journal provides a forum for the dissemination of novel insights and innovations across key disciplines involved in IBD care.
Crohn's disease. --- Crohn Disease. --- Inflammatory Bowel Diseases. --- Gastrointestinal Diseases. --- Digestive System Diseases. --- Digestive System Disease --- Disease, Digestive System --- Diseases, Digestive System --- System Disease, Digestive --- System Diseases, Digestive --- Functional Gastrointestinal Disorders --- Gastrointestinal Disorders, Functional --- Cholera Infantum --- Disease, Gastrointestinal --- Diseases, Gastrointestinal --- Disorder, Functional Gastrointestinal --- Disorders, Functional Gastrointestinal --- Functional Gastrointestinal Disorder --- Gastrointestinal Disease --- Gastrointestinal Disorder, Functional --- Infantum, Cholera --- Gastroenterology --- Bowel Diseases, Inflammatory --- Inflammatory Bowel Disease --- Crohn's Disease --- Crohn's Enteritis --- Inflammatory Bowel Disease 1 --- Regional Enteritis --- Colitis, Granulomatous --- Enteritis, Granulomatous --- Enteritis, Regional --- Ileitis, Regional --- Ileitis, Terminal --- Ileocolitis --- Crohns Disease --- Granulomatous Colitis --- Granulomatous Enteritis --- Regional Ileitides --- Regional Ileitis --- Terminal Ileitis --- Crohn disease --- Granulomatous colitis --- Granulomatous enteritis --- Regional enteritis --- Regional ileitis --- Terminal enteritis --- Inflammatory bowel diseases --- Digestive System Disorders --- Hepatobiliary Diseases --- Hepatobiliary Disorders --- Digestive System Disorder --- Hepatobiliary Disease --- Hepatobiliary Disorder --- System Disorders, Digestive --- Gastrointestinal Disorders --- Gastrointestinal Disorder --- Colitis. --- Irritable Bowel Syndrome. --- Colitides --- Colitis, Mucous --- Colon, Irritable --- Colitides, Mucous --- Irritable Bowel Syndromes --- Irritable Colon --- Mucous Colitides --- Mucous Colitis --- Syndrome, Irritable Bowel --- Syndromes, Irritable Bowel --- crohn's disease --- colitis --- inflammatory bowel disease
Listing 1 - 10 of 16 | << page >> |
Sort by
|